Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT‐IHF randomized clinical trial

AIMS: Qishen Yiqi dripping pills (QSYQ) may be beneficial in patients with ischaemic heart failure (IHF). We aimed to assess the efficacy and safety of QSYQ administered together with guideline‐directed medical therapy in patients with IHF. METHODS AND RESULTS: This prospective randomized, double‐bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Jingyuan, Zhang, Jian, Lam, Carolyn S.P., Zhu, Mingjun, Yao, Chen, Chen, Shutao, Liu, Zhongyong, Wang, Fengrong, Wang, Yonggang, Dai, Xiaohua, Niu, Tianfu, An, Dongqing, Miao, Yang, Xu, Tao, Dong, Bo, Ma, Xiaofeng, Zhang, Fengru, Wang, Xiaolong, Fan, Ruihong, Zhao, Yingqiang, Jiang, Tiemin, Zhang, Yuhui, Wang, Xianliang, Hou, Yazhu, Zhao, Zhiqiang, Su, Quan, Zhang, Junhua, Wang, Baohe, Zhang, Boli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754900/
https://www.ncbi.nlm.nih.gov/pubmed/32954647
http://dx.doi.org/10.1002/ehf2.12980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754900/
https://www.ncbi.nlm.nih.gov/pubmed/32954647
http://dx.doi.org/10.1002/ehf2.12980

Ejemplares similares